{"DataElement":{"publicId":"14741377","version":"1","preferredName":"Medical History Supplemental Qualifiers Dataset Neuroblastoma Diagnosis During Enrollment International Neuroblastoma Risk Group Classification System Stage","preferredDefinition":"The term that specifies the neuroblastoma stage as diagnosed.","longName":"SUPPMH_QVAL_MHSTAGE","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"14741376","version":"1","preferredName":"Medical History Supplemental Qualifiers Dataset Neuroblastoma Diagnosis","preferredDefinition":"A dataset containing supplemental information, specifically non-standard variables, to parent records in the medical history domain.:4 - PT  V 25.1_The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"10344514v1.00:14758276v1.00","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"10344514","version":"1","preferredName":"Medical History Supplemental Qualifiers Dataset","preferredDefinition":"A dataset containing supplemental information, specifically non-standard variables, to parent records in the medical history domain.","longName":"C147223","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medical History Supplemental Qualifiers Dataset","conceptCode":"C147223","definition":"A dataset containing supplemental information, specifically non-standard variables, to parent records in the medical history domain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DF76BCAD-08F3-1C30-E053-731AD00A15B6","latestVersionIndicator":"Yes","beginDate":"2022-05-20","endDate":null,"createdBy":"LISU","dateCreated":"2022-05-20","modifiedBy":"LISU","dateModified":"2022-05-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"14758276","version":"1","preferredName":"Neuroblastoma Diagnosis","preferredDefinition":"4 - PT  V 25.1_The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"10029260:C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuroblastoma","conceptCode":"10029260","definition":"4 - PT  V 25.1","evsSource":"MEDDRA_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"114B0219-C785-105F-E063-731AD00A90C6","latestVersionIndicator":"Yes","beginDate":"2024-02-13","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"10A5359A-65CB-6B41-E063-731AD00A431B","latestVersionIndicator":"Yes","beginDate":"2024-02-05","endDate":null,"createdBy":"RAGUNATHANU","dateCreated":"2024-02-05","modifiedBy":"MMADDINENI","dateModified":"2024-02-13","changeDescription":null,"administrativeNotes":"02/05/2024: Created for COG ANBL2131 UR","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5777232","version":"1","preferredName":"International Neuroblastoma Risk Group Classification System Stage","preferredDefinition":"A classification system developed to establish a consensus approach for pretreatment risk stratification of neuroblastomas._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"5777232v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Ms","valueDescription":"INRG Stage MS","ValueMeaning":{"publicId":"5777234","version":"1","preferredName":"INRG Stage MS","longName":"5777234","preferredDefinition":"INRG stage L1 or L2 neuroblastoma with metastatic disease confined to the skin and/or liver and/or bone marrow.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"INRG Stage MS","conceptCode":"C133431","definition":"INRG stage L1 or L2 neuroblastoma with metastatic disease confined to the skin and/or liver and/or bone marrow.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D754865-697F-4A91-E053-F662850AECC0","latestVersionIndicator":"Yes","beginDate":"2017-04-18","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D754865-699B-4A91-E053-F662850AECC0","beginDate":"2017-04-18","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-18","modifiedBy":"ONEDATA","dateModified":"2017-04-18","deletedIndicator":"No"},{"value":"M","valueDescription":"INRG Stage M","ValueMeaning":{"publicId":"5777235","version":"1","preferredName":"INRG Stage M","longName":"5777235","preferredDefinition":"Neuroblastoma with distant metastatic disease (except MS).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"INRG Stage M","conceptCode":"C133430","definition":"Neuroblastoma with distant metastatic disease (except MS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D754865-69A7-4A91-E053-F662850AECC0","latestVersionIndicator":"Yes","beginDate":"2017-04-18","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D754865-69C2-4A91-E053-F662850AECC0","beginDate":"2017-04-18","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-18","modifiedBy":"ONEDATA","dateModified":"2017-04-18","deletedIndicator":"No"},{"value":"L2","valueDescription":"INRG Stage L2","ValueMeaning":{"publicId":"5777236","version":"1","preferredName":"INRG Stage L2","longName":"5777236","preferredDefinition":"Locoregional neuroblastoma with one or more image defined risk factors (IDRFs).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"INRG Stage L2","conceptCode":"C133429","definition":"Locoregional neuroblastoma with one or more image defined risk factors (IDRFs).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D754865-69CE-4A91-E053-F662850AECC0","latestVersionIndicator":"Yes","beginDate":"2017-04-18","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D754865-69E9-4A91-E053-F662850AECC0","beginDate":"2017-04-18","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-18","modifiedBy":"ONEDATA","dateModified":"2017-04-18","deletedIndicator":"No"},{"value":"L1","valueDescription":"INRG Stage L1","ValueMeaning":{"publicId":"5777237","version":"1","preferredName":"INRG Stage L1","longName":"5777237","preferredDefinition":"Locoregional neuroblastoma without image defined risk factors (IDRFs).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"INRG Stage L1","conceptCode":"C133428","definition":"Locoregional neuroblastoma without image defined risk factors (IDRFs).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D754865-69F5-4A91-E053-F662850AECC0","latestVersionIndicator":"Yes","beginDate":"2017-04-18","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D754865-6A10-4A91-E053-F662850AECC0","beginDate":"2017-04-18","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-18","modifiedBy":"ONEDATA","dateModified":"2017-04-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6010105","version":"1","preferredName":"International Neuroblastoma Risk Group Classification System Stage","preferredDefinition":"A classification system developed to establish a consensus approach for pretreatment risk stratification of neuroblastomas.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C102563:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Neuroblastoma Risk Group Classification System","conceptCode":"C102563","definition":"A classification system developed to establish a consensus approach for pretreatment risk stratification of neuroblastomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C3B0F64-75B1-0543-E053-F662850AF356","latestVersionIndicator":"Yes","beginDate":"2017-10-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-24","modifiedBy":"ONEDATA","dateModified":"2017-10-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D754865-6968-4A91-E053-F662850AECC0","latestVersionIndicator":"Yes","beginDate":"2017-04-18","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-18","modifiedBy":"COOPERM","dateModified":"2017-10-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Neuroblastoma Stage","url":null,"context":"COG"},{"name":"COG_Text1","type":"Alternate Question Text","description":"What is patient's stage at time of enrollment onto ANBL2131?","url":null,"context":"COG"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"10A54D8C-24FD-705B-E063-731AD00A5E3E","latestVersionIndicator":"Yes","beginDate":"2024-02-05","endDate":null,"createdBy":"RAGUNATHANU","dateCreated":"2024-02-05","modifiedBy":"MMADDINENI","dateModified":"2024-02-13","changeDescription":null,"administrativeNotes":"02/05/2024: Created for ANBL2131 UR","unresolvedIssues":null,"deletedIndicator":"No"}}